Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
The National Brain Mapping Laboratory (NBML)
With
Leibniz Research Centre for Working Environment and Human Factors
Neuroelectrics Corporation
Zanjan University of Medical Sciences
RWTH Aachen University
Age
18–60
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Meet DSM-5 criteria for a moderate-to-severe major depression, primarily by a DSM-5-based structured interview by a licensed psychiatrist, confirmed by score on Hamilton Rating Scale for Depression (HAMD)
being 18-60 years old
providing written informed consent
If female, negative urine pregnancy test
Treatment naïve or on a stable standard antidepressant regimen (including selective serotonin reuptake inhibitors (SSRIs), serotonin-noradrenaline reuptake inhibitors (SNRIs), monoamine oxidase inhibitors (MOAIs) or tricyclics (TCAs)) with no change in treatment 6-weeks prior to and during the tDCS intervention
You may not be if
smoker
pregnancy
alcohol or substance dependence
history of seizure
history of neurological disorder
comorbid Schizophrenia Axis I disorder, bipolar disorder, substance abuse or dependence, dementia, personality disorder
history of head injury
currently receiving any form of Cognitive Behavioral Therapy, Dialectical Behavioral Therapy, or Acceptance and Commitment Therapy
Presence of ferromagnetic objects in the body that are contraindicated for brain stimulation of the head (pacemakers or other implanted electrical devices, brain stimulators, some types of dental implants, aneurysm clips, metallic prostheses, permanent eyeliner, implanted delivery pump, or shrapnel fragments)
Clareo Health | Optimizing tDCS Protocol for Clinical Use in Major Depressive Disorder
